Elming H - Search Results

1

A benefit-risk assessment of class III antiarrhythmic agents.

Elming H, Brendorp B, Pehrson S, Pedersen OD, Køber L, Torp-Petersen C. Elming H, et al. Expert Opin Drug Saf. 2004 Nov;3(6):559-77. doi: 10.1517/14740338.3.6.559. Expert Opin Drug Saf. 2004. PMID: 15500415 Review.

2

Classification of sudden and arrhythmic death.

Torp-Pedersen C, Køber L, Elming H, Burchart H. Torp-Pedersen C, et al. Among authors: elming h. Pacing Clin Electrophysiol. 1997 Oct;20(10 Pt 2):2545-52. doi: 10.1111/j.1540-8159.1997.tb06103.x. Pacing Clin Electrophysiol. 1997. PMID: 9358501

3

Use of left ventricular ejection fraction or wall-motion score index in predicting arrhythmic death in patients following an acute myocardial infarction. The TRACE Study Group.

Køber L, Torp-Pedersen C, Elming H, Burchardt H. Køber L, et al. Among authors: elming h. Pacing Clin Electrophysiol. 1997 Oct;20(10 Pt 2):2553-9. doi: 10.1111/j.1540-8159.1997.tb06104.x. Pacing Clin Electrophysiol. 1997. PMID: 9358502 Review.

4

The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens.

Elming H, Holm E, Jun L, Torp-Pedersen C, Køber L, Kircshoff M, Malik M, Camm J. Elming H, et al. Eur Heart J. 1998 Sep;19(9):1391-400. doi: 10.1053/euhj.1998.1094. Eur Heart J. 1998. PMID: 9792266 Clinical Trial.

5

Spontaneous coronary artery dissection. Case report and literature review.

Elming H, Køber L. Elming H, et al. Scand Cardiovasc J. 1999;33(3):175-9. doi: 10.1080/14017439950141821. Scand Cardiovasc J. 1999. PMID: 10399807 Free article. Review.

6

Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function.

Brendorp B, Elming H, Jun L, Køber L, Malik M, Jensen GB, Torp-Pedersen C. Brendorp B, et al. Among authors: elming h. Circulation. 2001 Feb 13;103(6):831-5. doi: 10.1161/01.cir.103.6.831. Circulation. 2001. PMID: 11171791

7

Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide.

Brendorp B, Elming H, Jun L, Køber L, Malik M, Jensen GB, Torp-Pedersen C; DIAMOND Study Group. Brendorp B, et al. Among authors: elming h. Circulation. 2001 Mar 13;103(10):1422-7. doi: 10.1161/01.cir.103.10.1422. Circulation. 2001. PMID: 11245647 Clinical Trial.

8

[Why is QT interval interesting?].

Elming H, Sonne J, Lublin HK. Elming H, et al. Ugeskr Laeger. 2002 Feb 4;164(6):750-4. Ugeskr Laeger. 2002. PMID: 11851179 Review. Danish.

9

Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure.

Brendorp B, Elming H, Jun L, Køber L, Torp-Pedersen C; DIAMOND Study Group. Danish Investigations Of Arrhythmia and Mortality On Dofetilide. Brendorp B, et al. Among authors: elming h. Eur J Heart Fail. 2002 Mar;4(2):201-6. doi: 10.1016/s1388-9842(01)00235-5. Eur J Heart Fail. 2002. PMID: 11959050 Free article. Clinical Trial.

10

QTc interval in the assessment of cardiac risk.

Elming H, Brendorp B, Køber L, Sahebzadah N, Torp-Petersen C. Elming H, et al. Card Electrophysiol Rev. 2002 Sep;6(3):289-94. doi: 10.1023/a:1016345412555. Card Electrophysiol Rev. 2002. PMID: 12114854 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters